Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00540_DB01045> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00540_DB01045 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00540_DB01045 label "DDI between Nortriptyline and Rifampicin - The rifamycin, rifampin, may decrease the effect of the tricyclic antidepressant, nortriptyline, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nortriptyline if rifampin is initiated, discontinued or dose changed. [drugbank_resource:DB00540_DB01045]" assertion.
- drugbank_resource:DB00540_DB01045 identifier "drugbank_resource:DB00540_DB01045" assertion.
- drugbank_resource:DB00540_DB01045 title "DDI between Nortriptyline and Rifampicin - The rifamycin, rifampin, may decrease the effect of the tricyclic antidepressant, nortriptyline, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nortriptyline if rifampin is initiated, discontinued or dose changed." assertion.